Attorney Examines Unsavory Marketing Tactics by Johnson & Johnson
Posted on Mar 12, 2010
My colleague Jim Lewis wrote about a recent lawsuit filed against the drug manufacturer Johnson & Johnson (J&J). The lawsuit alleges that J&J violated FDA laws by improperly marketing the drug Risperdal as a treatment for dementia when it was only certified as an antipsychotic. This isn't the first time J&J has gotten into legal trouble over questionable marketing techniques. Check out the blog to learn more.
Read More About Attorney Examines Unsavory Marketing Tactics by Johnson & Johnson...